Company Overview
| Stock Name | 鳳凰醫療集團 |
|---|---|
| Stock Code | 01515 |
| Company Full Name | 鳳凰醫療集團 |
| Industry | 居民服務 |
| Principal Activities | 主要在中國提供綜合醫院服務、醫院管理服務及相關供應鏈業務。 |
| Listing Date | 2013-11-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市西城區太平街6號富力摩根中心E-825室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.phg.com.cn |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 7.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 741,350,520 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 10.0 |
|---|---|
| First Day Open | HK$ 8.58 |
| First Day Change | 35.50% |
| First Day Volume | 210640000.0 |
| First Day Turnover | 1968700000.0 |
Use of Proceeds
| Use of Proceeds | 1、募集資金凈額的42%或58100萬元，將為本集團醫院網絡的擴展（透過公私合營和收購進行，以北京為策略重點）提供資金 2、募集資金凈額的25%或34000萬元，將就Speed Key Limited向債券持有人發行的可交換債券，以12%的年利率悉數償還本集團主要股東Speed Key Limited的未償還貸款 3、募集資金凈額的10%或10100萬元，將在2015年前作出資本支出，為健宮醫院重建若干設施及購買醫療設備 4、募集資金凈額的7%或34000萬元，將在2015年前，在集團層面建立先進的臨床測試及實驗中心 5、募集資金凈額的6%或8000萬元，將在2015年前向燕化醫院集團支付資本承擔 6、募集資金凈額的10%或13800萬元，將用于營運資金及其他一般企業用途 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
德意志证券亚洲有限公司 CE AAJ984
高盛（亚洲）有限责任公司 CE ACC536
Overall Coordinators (2)
德意志银行香港分行
高盛（亚洲）有限责任公司 CE ACC536
Joint Bookrunners (3)
德意志银行香港分行
高盛（亚洲）有限责任公司 CE ACC536
交银国际证券有限公司 CE APJ121
Joint Lead Managers (3)
德意志银行香港分行
高盛（亚洲）有限责任公司 CE ACC536
交银国际证券有限公司 CE APJ121
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 于海 |
|---|---|
| Company Secretary | 鐘明輝 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 華潤(集團)有限公司(36.58%)；三菱日聯金融集團(5.98%) |
|---|
